Fulgent Genetics Earnings Estimates, EPS & Revenue | NASDAQ:FLGT

Comments

Fulgent Genetics Inc Earnings Estimates

FLGTNASDAQ

Trade with Public

$14.77

0.090.61%

At close: Mar 13, 5:00 PM EST

$14.77

N/A

After Hours: 4:00 PM EST

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Fulgent Genetics Earnings Estimates, EPS & Revenue | NASDAQ:FLGT

Fulgent Genetics (FLGT) is scheduled to report Q1 earnings on May 1, 2026. Analysts estimate EPS of $-0.48 and quarterly revenue of $68.62M.

In the most recent quarter (Q4), Fulgent Genetics reported EPS of $0.16, beating estimates of $-0.09 by 2.78%. Revenue came in at $83.34M, missing the estimate of $85.38M by 0.02%.

Fulgent Genetics has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Fulgent Genetics has averaged an EPS surprise of 1.65% and a revenue surprise of 0.04%.

Earnings Date

May 1

EPS Estimate

$-0.480

Quarterly Revenue Estimate

$68.62M

Annual Revenue
(as of Dec 31)

$322.67M

Fulgent Genetics Earnings History

Analyze the earnings history of Fulgent Genetics using advanced sorting and filters.

Loading calendar...

Fulgent Genetics (FLGT) Earnings Per Share

The chart below shows Fulgent Genetics's reported EPS compared to analyst estimates over recent quarters.

Fulgent Genetics (FLGT) Revenue

The chart below shows Fulgent Genetics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Fulgent Genetics (NASDAQ:FLGT) reporting earnings?

Fulgent Genetics (FLGT) is scheduled to report earnings on May 1, 2026. The last reported earnings were for reported on February 27, 2026 for Q4.

What were the latest earnings per share (EPS) for Fulgent Genetics (NASDAQ:FLGT)?

The Actual EPS was $0.16, which beat the estimate of $-0.09.

What were Fulgent Genetics’s (NASDAQ:FLGT) revenues?

The Actual Revenue was $83.34M, which missed the estimate of $85.38M.

People Also Watch

Prenetics Global Ltd

NASDAQ:PRE

$20.72

Cross Country Healthcare Inc

InnovAge Holding Corp

SBC Medical Group Holdings Inc

NASDAQ:SBC

$3.56

Fulgent Genetics Earnings Estimates, EPS & Revenue | NASDAQ:FLGT

Fulgent Genetics (FLGT) is scheduled to report Q1 earnings on May 1, 2026. Analysts estimate EPS of $-0.48 and quarterly revenue of $68.62M.

In the most recent quarter (Q4), Fulgent Genetics reported EPS of $0.16, beating estimates of $-0.09 by 2.78%. Revenue came in at $83.34M, missing the estimate of $85.38M by 0.02%.

Fulgent Genetics has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Fulgent Genetics has averaged an EPS surprise of 1.65% and a revenue surprise of 0.04%.

Earnings Date

May 1

EPS Estimate

$-0.480

Quarterly Revenue Estimate

$68.62M

Annual Revenue
(as of Dec 31)

$322.67M